Combined Oral Contraceptive Pill Initiation in a Patient With Major Depressive Disorder, Premenstrual Dysphoric Disorder, Social Anxiety, Panic Disorder, and Histrionic Personality Disorder

REFERENCES

1. ↵
   1. Cunningham J,
   2. Yonkers KA,
   3. O'Brien S,
   4. Eriksson E

   Update on research and treatment of premenstrual dysphoric disorder. Harv Rev Psychiatry. 2009; 17 2: 120- 137. pmid:19373620

   OpenUrlCrossRefPubMed
2. ↵
   1. Pilver CE,
   2. Libby DJ,
   3. Hoff RA

   Premenstrual dysphoric disorder as a correlate of suicidal ideation, plans, and attempts among a nationally representative sample. Soc Psychiatry Psychiatr Epidemiol. 2013 3; 48 3: 437- 446. pmid:22752111

   OpenUrlCrossRefPubMed
3. ↵
   1. Bhatia SC,
   2. Bhatia SK

   Diagnosis and treatment of premenstrual dysphoric disorder. Am Fam Physician. 2002 10 1; 66 7: 1239- 1249. pmid:12387436

   OpenUrlPubMedWeb of Science
4. ↵
   1. Andréen, L,
   2. Nyberg S,
   3. Turkmen S,
   4. van Wingen G,
   5. Fernández G,
   6. Bäckström T

   Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology. 2009 9; 34 8: 1121- 1132. pmid:19272715

   OpenUrlCrossRefPubMed
5. ↵
   1. Freeman EW,
   2. Frye CA,
   3. Rickels K,
   4. Martin PA,
   5. Smith SS

   Allopregnanolone levels and symptom improvement in severe premenstrual syndrome. J Clin Psychopharmacol. 2002 10; 22 5: 516- 520. pmid:12352277

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Borrow AP,
   2. Cameron NM

   Estrogenic mediation of serotonergic and neurotrophic systems: implications for female mood disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2014 10 3; 54: 13- 25. pmid:24865152

   OpenUrlPubMed
7. ↵
   1. Rojansky N,
   2. Halbreich U,
   3. Zander K,
   4. Barkai A,
   5. Goldstein S

   Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol Obstet Invest. 1991; 31 3: 146- 152. pmid:1649111

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Inoue Y,
   2. Terao T,
   3. Iwata N,
   4. et al.

   Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests. Psychopharmacology (Berl). 2007 2; 190 2: 213- 219. pmid:17072588

   OpenUrlPubMed
9. ↵
   1. Thys-Jacobs S,
   2. McMahon D,
   3. Bilezikian JP

   Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder. J Clin Endocrinol Metab. 2007 8; 92 8: 2952- 2959. pmid:17488795

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Rosenstein DL,
    2. Elin RJ,
    3. Hosseini JM,
    4. Grover G,
    5. Rubinow DR

    Magnesium measures across the menstrual cycle in premenstrual syndrome. Biol Psychiatry. 1994 4 15; 35 8: 5575- 5561.

    OpenUrl
11. ↵
    1. Liu B,
    2. Wang G,
    3. Gao D,
    4. et al.

    Alterations of GABA and glutamate-glutamine levels in premenstrual dysphoric disorder: a 3T proton magnetic resonance spectroscopy study. Psychiatry Res. 2015 1 30; 231 1: 64- 70. pmid:25465316

    OpenUrlPubMed
12. ↵
    1. Vigod SN,
    2. Frey BN,
    3. Soares CN,
    4. Steiner M

    Approach to premenstrual dysphoria for the mental health practitioner. Psychiatr Clin North Am. 2010 6; 33 2: 257- 272. pmid:20385336

    OpenUrlCrossRefPubMed
13. ↵
    1. Wyatt KM,
    2. Dimmock PW,
    3. O'Brien PM

    Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2002; (4):CD001396.
14. 1. Halbreich U,
    2. Freeman EW,
    3. Rapkin AJ,
    4. et al.

    Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder. Contraception. 2012 1; 85 1: 19- 27. pmid:22067793

    OpenUrlPubMed
15. ↵
    1. Marr J,
    2. Niknian M,
    3. Shulman LP,
    4. Lynen R

    Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3 mg administered in a 24/4 regimen. Contraception. 2011 7; 84 1: 81- 86. doi:10.1016/j.contraception.2011.10.010. pmid:21664515

    OpenUrlCrossRefPubMed
16. ↵
    1. Freeman EW,
    2. Halbreich U,
    3. Grubb GS,
    4. et al.

    An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. Contraception. 2012 5; 85 5: 437- 445. doi:10.1016/j.contraception.2011.09.010. pmid:22152588

    OpenUrlCrossRefPubMed